Patent Strategy + Prosecution

Federal Circuit Agrees with the USPTO on Inventors: Only Human, after All

AI as a Patent Inventor—An Update From South Africa and Australia

European Union Adopts Regulation to Extend Term of Community Plant Variety Rights in Europe for Varieties of Certain Plant Species

AI as a Patent Inventor – an Update from South Africa and Australia

The European Commission’s Take on Novel Genomic Techniques (NGTs) in Light of CJEU’s Ruling in Case C-528/16

Pay-for-Delay Has a Tough (Antitrust) Time at EU Top Court

Morrison Foerster Named Patent Strategy Firm of the Year by 2022 LMG Life Sciences Americas Awards

Motions To Amend Can Create ‘Super Patents’ but They’re Hard to Get

China’s New Seed Law: Molecular Varieties and Macro Developments

MoFo Partners with Nucleate for 2022 Activator Program

Morrison & Foerster Elects 22 Partners

Two Morrison & Foerster Lawyers Named Top Healthcare Lawyers by Daily Journal

AI & Robotics 2022

2022 MoFo Fall Patent Law Virtual Course

World Agri-Tech Innovation Summit

Navigating the Challenging Antibody Patent Landscape

Precision Medicine World Conference 2022

Future Food-Tech Alternative Protein Summit 2022

Toward a Therapy for COVID-19: The Science and Legal Considerations

Toward a Vaccine for COVID-19: The Science and Legal Considerations

Applying AI and Data Science to the Fight Against COVID-19: The Science and Legal Considerations

Unpacking the Science and Legal Considerations of COVID-19 Testing